Table 4.
Treatment-emergent adverse events
Adverse event | Grade 1-2 | Grade 3 | Grade 4 |
---|---|---|---|
Hematologic events | |||
Thrombocytopenia | 2 (6.9) | 0 | 1 (3.4) |
Neutropenia | 1 (3.4) | 0 | 0 |
Anemia | 4 (13.8) | 0 | 0 |
Gastrointestinal events | |||
Diarrhea | 3 (10.3) | 1 (3.4) | 0 |
Nausea | 4 (13.8) | 0 | 0 |
Neurologic events | |||
Peripheral neuropathy | 6 (20.7) | 0 | 0 |
Seizure | 1 (3.4) | 0 | 0 |
Infections | |||
Pneumonia | 0 | 1 (3.4) | 0 |
Eye infection | 2 (6.9) | 0 | 0 |
Skin infection | 0 | 1 (3.4) | 0 |
Upper respiratory tract infection | 3 (10.3) | 0 | 0 |
Other conditions | |||
Fatigue | 5 (17.2) | 0 | 0 |
Skin rash | 5 (17.2) | 0 | 0 |
Pyrexia | 4 (13.8) | 0 | 0 |
Elevated aminotransferase | 2 (6.9) | 0 | 0 |
Hypertension | 2 (6.9) | 0 | 0 |
Values are presented as number (%).